TCR2
DEAD

Serial Number

86660163

Owner

TCR2 THERAPEUTICS INC.

Attorney

Brandon P. Leahy

First Use Date

Jul 24, 2019

Filing Date

Jun 11, 2015

Add to watchlist:

No watchlists yet
View on USPTO

TCR2 Trademark

Serial Number: 86660163 • Registration: 5903400

TCR2 is a trademark filed by TCR2 THERAPEUTICS INC. on June 11, 2015. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

TCR2 THERAPEUTICS INC. (5 trademarks)

100 BINNEY STREET, SUITE 710
CAMBRIDGE, MA 02142

Entity Type: 03

TCR2, Inc. (2 trademarks)

675 West Kendall Street, Suite 1
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

June 11, 2015

Registration Date

November 5, 2019

First Use Anywhere

July 24, 2019

First Use in Commerce

July 24, 2019

Published for Opposition

July 12, 2016

Cancellation Date

May 15, 2026

Goods & Services

Biotechnology and pharmaceutical products, namely, therapeutic cells, therapeutic proteins and therapeutic nucleic acids for human use for the treatment and prevention of cancer, inflammation and inflammatory diseases; pharmaceutical preparations for human use, namely, biotherapeutics, medicines, and therapeutics, namely, pharmaceutical polypeptides, pharmaceutical antibodies, pharmaceutical nucleic acids, polypeptide-based therapeutics, cell-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics for the treatment and prevention of cancer, inflammation and inflammatory diseases

Scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics; providing information on the subject of scientific research in the fields of pharmaceuticals, pharmaceutical research and development, laboratory testing, biotechnology, medicine, biologics, biotherapeutics, biosimilars, cancer treatment, oncology, and therapeutics, namely, polypeptide-based therapeutics, RNA-based therapeutics, and DNA-based therapeutics

Filing History

CANCELLED SEC. 8 (6-YR)
May 15, 2026 C8..
WITHDRAWAL OF ATTORNEY GRANTED
Aug 20, 2025 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Aug 20, 2025 WOAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 5, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Nov 5, 2019 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 4, 2019 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 3, 2019 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2019 CRFA
ASSIGNED TO LIE
Sep 9, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 3, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 3, 2019 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 29, 2019 GNRN
NON-FINAL ACTION E-MAILED
Aug 29, 2019 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 29, 2019 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Aug 6, 2019 SUPC
USE AMENDMENT FILED
Aug 1, 2019 IUAF
TEAS STATEMENT OF USE RECEIVED
Aug 1, 2019 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2019 EXRA
SOU EXTENSION 5 GRANTED
Feb 5, 2019 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 4, 2019 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 30, 2019 ASGN
SOU EXTENSION 5 FILED
Jan 28, 2019 EXT5
SOU TEAS EXTENSION RECEIVED
Jan 28, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 25, 2018 EXRA
SOU EXTENSION 4 GRANTED
Jul 23, 2018 EX4G
SOU EXTENSION 4 FILED
Jul 23, 2018 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 23, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2018 EXRA
SOU EXTENSION 3 GRANTED
Jan 30, 2018 EX3G
SOU EXTENSION 3 FILED
Jan 30, 2018 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 30, 2018 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 6, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 6, 2017 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 21, 2017 EXRA
SOU EXTENSION 2 GRANTED
Jul 19, 2017 EX2G
SOU EXTENSION 2 FILED
Jul 19, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 19, 2017 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 1, 2017 EXRA
SOU EXTENSION 1 GRANTED
Jan 30, 2017 EX1G
SOU EXTENSION 1 FILED
Jan 30, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 30, 2017 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 6, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 12, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jul 12, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 22, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jun 6, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
May 28, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
May 28, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 28, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
May 28, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 28, 2016 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 3, 2016 GNRN
NON-FINAL ACTION E-MAILED
May 3, 2016 GNRT
NON-FINAL ACTION WRITTEN
May 3, 2016 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2016 TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 7, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 7, 2016 CRFA
ASSIGNED TO LIE
Mar 31, 2016 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 21, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 21, 2016 TROA
TEAS VOLUNTARY AMENDMENT RECEIVED
Mar 21, 2016 PARI
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2015 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2015 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2015 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2015 DOCK
NOTICE OF PSEUDO MARK E-MAILED
Jun 17, 2015 MPMK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2015 NWOS
NEW APPLICATION ENTERED
Jun 15, 2015 NWAP